A consultant who has analyzed healthcare policy over many decades declares that MA is in the middle of a fundamental reset ...

HeartFlow, which makes AI tools to analyze cardiac images, sued its rival Cleerly, alleging infringement on six patents. Cleerly is pushing back.

Rep. Greg Murphy (R-North Carolina) introduced the Every Dollar Counts Act on Tuesday. It would ensure out-of-pocket costs for covered prescription drugs are applied toward patients’ deductibles and ...

President Donald Trump’s 2027 budget proposes deep healthcare cuts, raising concerns about harm to patients and research.

The Department of Justice has sued both OhioHealth and NewYork-Presbyterian Hospital this year, alleging that they use ...

Another AI startup helping providers automate administrative processes picked up a significant round of capital on Thursday. Luminai CEO Kesava Kirupa Dinakaran said the startup’s platform is built ...

In today’s fast-moving, hyper-connected world, legal and compliance teams shield organizations from a constant stream of internal and external threats to sensitive data. Effectively countering these ...

Hospitals’ financial positioning is somewhat stable but still under significant pressure, mainly from rising costs and reimbursement issues, according to data released last week by Kaufman Hall. The ...

Every year, thousands of Americans end up in emergency rooms for issues that could have been treated — and often prevented — in a dentist’s office. From a small cavity that goes unnoticed to severe ...

In June of 2025, health plans made a series of commitments to improve prior authorization. On Tuesday, insurer advocacy organization AHIP and Blue Cross Blue Shield Association gave their first update ...

Amazon’s health benefits program continues to expand. Amazon customers eligible for Teladoc Health’s services in diabetes, hypertension, pre-diabetes and weight management can now enroll directly ...

Insmed’s new drug, Brinsupri, is still projected to reach blockbuster status, but an inflammatory skin disorder is no longer in the picture following a mid-stage clinical trial failure in this ...